FDA Calendars Drug Approvals Clinical Trial Calendar Ratings Changes Upgrades Downgrades Cov Initiations Cov. Reiterated Economy Economic News US Europe Asia Global Economic Calendar Economic Scorecard Cryptocurrency Crypto Cryptocurrency Blockchain Markets Markets Morning Mkt Analysis US Commentary Europe...
FDA Calendars Drug Approvals Clinical Trial Calendar Ratings Changes Upgrades Downgrades Cov Initiations Cov. Reiterated Economy Economic News US Europe Asia Global Economic Calendar Economic Scorecard Crypto Cryptocurrency Blockchain Markets Morning Mkt Analysis ...
FDA Calendars Drug Approvals Clinical Trial Calendar Ratings Changes Upgrades Downgrades Cov Initiations Cov. Reiterated Economy Economic News US Europe Asia Global Economic Calendar Economic Scorecard Cryptocurrency Crypto Cryptocurrency Blockchain Markets ...
FDA Calendars Drug Approvals Clinical Trial Calendar Ratings Changes Upgrades Downgrades Cov Initiations Cov. Reiterated Economy Economic News US Europe Asia Global Economic Calendar Economic Scorecard Cryptocurrency Crypto Cryptocurrency Blockchain Markets ...
FDA decision on Uplizna for the treatment of Immunoglobulin G4-related disease BusinessView More JPMorgan Stock Gains On Q1 Results Above Street, AUM Strength April 11, 2025 08:12 ET Shares of JPMorgan Chase & Co. were gaining around 2 percent in the pre-market activity on the NYSE after...
FDA Calendars Drug Approvals Clinical Trial Calendar Ratings Changes Upgrades Downgrades Cov Initiations Cov. Reiterated Economy Economic News US Europe Asia Global Economic Calendar Economic Scorecard Cryptocurrency Crypto Cryptocurrency Blockchain Markets Markets Morning Mkt Analysis US Commentary Europe...
FDA Calendars Drug Approvals Clinical Trial Calendar Ratings Changes Upgrades Downgrades Cov Initiations Cov. Reiterated Economy Economic News US Europe Asia Global Economic Calendar Economic Scorecard Cryptocurrency Crypto Cryptocurrency Blockchain Forex ...
Find out what's going on in the Forex, Currency, Commodities, Treasury Markets with our up-to-date analysis and news coverage. Stay ahead of your competition by being well informed!
FDA decision on Nipocalimab for the treatment of generalized myasthenia gravis Aldeyra Therapeutics, Inc. (ALDX) Reproxalap (Resubmitted NDA) 04/02/2025 FDA decision on Reproxalap for the treatment of the signs and symptoms of dry eye disease ...
FDA Calendars Drug Approvals Clinical Trial Calendar Ratings Changes Upgrades Downgrades Cov Initiations Cov. Reiterated Economy Economic News US Europe Asia Global Economic Calendar Economic Scorecard Cryptocurrency Crypto Cryptocurrency Blockchain Markets ...